0.050.09975 0

Webinar: Normative and Contractual Framework for Teleconsultation Practices in Primary Care Clinics

Wednesday 31 Mar 2021
From 12PM To 1:30PM

Mélanie Bourassa Forcier, Full Professor at the Faculty of Law of the Université de Sherbrooke, Deputy Commissioner of Ethics and Regulations for the Commissioner of Health and Welfare, Main Researcher of the theme Innovation and Digital Transformation at CIRANO, and Maude Laberge, Assistant Professor in the Department of Operations and Decision Systems at the Université Laval, CIRANO Researcher, presented the results of the CIRANO report "Encadrement normatif et contractuel des pratiques de téléconsultation en clinique de première ligne".

 

Until the COVID-19 pandemic, teleconsultation services offered by general practitioners in Quebec were severely limited mainly because they were not remunerated as they were not recognized as insurable medical acts. The decree of March 16, 2020, adopted in the context of a health emergency, now allows this remuneration in the same way as the remuneration associated with the patient's visit to the clinic. Numerous benefits are recognized and associated with front-line teleconsultation if this teleconsultation is well supervised. The purpose of this project is to examine good practices in the supervision of teleconsultation and to propose recommendations before the next remuneration agreement with general practitioners is negotiated. In particular, we recommend mandatory training, legislative clarification regarding the right of private insurers to reimburse teleconsultation and various remuneration terms depending on the type of teleconsultation. Finally, we feel it is imperative to quickly commission a detailed study on the benefits and costs of teleconsultation in Quebec.

Mélanie Bourassa Forcier

A CIRANO Researcher and Fellow since 2010, Main Researcher of the theme Innovation and Digital Transformation, Mélanie Bourassa Forcier is Full Professor at the Faculty of Law of the Université de Sherbrooke. She directs the programs in Health Law and Policy and Life Sciences Law. She is also a member of the Commission de l'éthique en science et en technologie and Deputy Commissioner of Ethics and Regulations for the Commissioner of Health and Welfare.

Holding a Ph.D.in Pharmaceutical Patent Law from McGill University, has expertise in the regulatory framework relating to the marketing and reimbursement of new medical technologies. She is particularly interested in their potential use to make a health care system more efficient, the incentives that encourage their development and the standards that may represent barriers to their implementation in health care systems. She is currently focusing her research on the legal issues (privacy, patents, marketing, liability) related to the implementation of artificial intelligence in the health sector.

She sat on the Board of Directors of the Montreal Heart Institute for nearly 5 years, where she chaired the Risk Management and Vigilance Committees. She has been called upon to present various conferences in London and in the United States on the subject.She has edited and published numerous books and articles on the subject of pharmaceutical regulation and health law. She has been the recipient of a number of prestigious awards and fellowships, including a SSHRC Doctoral Fellowship and the Commonweatlh Fellowship.

[ - ]
[ + ]

Maude Laberge

A CIRANO Researcher since 2020, Maude Laberge is Assistant Professor in the Department of Operations and Decision Systems at the Université Laval.

Holding a Ph.D. in Health Services Research from the University of Toronto, her research interests are primary care, health economics, performance measurement.

[ - ]
[ + ]